Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Harmony Biosciences Holdings Inc.
HRMY | US
32.14
USD2.61
8.84%
HRMY | US
About Harmony Biosciences Holdings Inc.
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
21/04/2026
Close
32.14
Open
29.49
High
34.99
Low
28.90
Harmony Biosciences Holdings Inc. a commercial-stage pharmaceutical company focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. It offers WAKIX (pitolisant) a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony Biosciences II Inc. and changed its name to Harmony Biosciences Holdings Inc. in February 2020. Harmony Biosciences Holdings Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting Pennsylvania.
View LessHRMY | US
Risk
40.2
Sharpe
0.19
Luna's Score
58/100
Recommendation
Hold
Luna says (HRMY | US)
What's Working
Positive Momentum
Strength based on increasing price with high volume
High Current Volume and Positive 1-Day Return
Low Market Beta (-0.4 to 0.8)
Strong Revenue Growth (> 10%)
What's not Working
Smallcap (300M - 2B USD)
High Short percentage (> 15%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
45.1%1 month
40.2%3 months
48.6%6 months
44.8%Returns
Fundamental Ratios
PE
18.16
Fwd. PE
8.79
Price to book
3.69
Debt to equity
0.41
Debt to assets
0.26
Ent. to EBITDA
8.69
Ent. to rev.
2.78
PEG
-
Other Fundamentals
EBITDA
202.50M
MarketCap
1.83B
MarketCap(USD)
1.83B
Div. yield
-
Op. margin
12.36
Erngs. growth
-64.30
Rev. growth
28.80
Ret. on equity
22.47
Short ratio
17.70
Short perc.
67.07
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
7.72
Range1M
8.54
Range3M
12.47
Volumes: Market Activity
Rel. volume
4.95
Price X volume
126.00M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 8.69 | - | Expensive |
| Ent. to Revenue | 2.78 | - | Cheaper |
| PE Ratio | 18.16 | 41.03 | Cheaper |
| Price to Book | 3.69 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 48.63 | - | Lower Risk |
| Debt to Equity | 0.41 | -1.23 | Expensive |
| Debt to Assets | 0.26 | 0.25 | Par |
| Market Cap | 1.83B | - | Emerging |
